Latest News
Via The Motley Fool · May 14, 2025
Via The Motley Fool · May 14, 2025
A 90-day pause on embargo-style US-China trade tariffs has revived bullish spirits.
Via Talk Markets · May 14, 2025
The US dollar is extending yesterday's pullback after Monday's sharp rally.
Via Talk Markets · May 14, 2025
President Trump’s “Liberation Day” announcement of imposing significant tariffs on the rest of the world triggered a steep and scary sell-off in the stock market.
Via Talk Markets · May 14, 2025
XRP (CRYPTO: XRP) has surged 416% over the past year, with recent market data pointing to a strong undercurrent of accumulation despite heightened speculation.
Via Benzinga · May 14, 2025
After cannabis healed their rift, Los Arias and his father launched Flostar Group. Now he's speaking at Benzinga's June conference.
Via Benzinga · May 14, 2025
Novo Nordisk and Septerna enter $2.2 billion deal to develop oral small-molecule therapies targeting obesity, diabetes, and cardiometabolic diseases.
Via Benzinga · May 14, 2025
Via Benzinga · May 14, 2025
Via Benzinga · May 14, 2025
Zijin Mining plans to spin off its offshore gold assets in a Hong Kong IPO.
Via Benzinga · May 14, 2025
The recall covers model years 2022 to 2024 of the Lincoln Navigator and Ford Expedition vehicles.
Via Stocktwits · May 14, 2025
This digital payment services provider is likely to get a lift from China's initiatives to boost domestic consumption.
Via Benzinga · May 14, 2025
Super Micro Computer Inc (NASDAQ:SMCI) shares are soaring again Wednesday after rising 16% on Tuesday. Here's a look at what's going on.
Via Benzinga · May 14, 2025
Wireless chipmaker Qualcomm (NASDAQ:QCOM) beat Wall Street’s revenue expectations in Q1 CY2025, with sales up 16.9% year on year to $10.98 billion. The company expects next quarter’s revenue to be around $10.3 billion, close to analysts’ estimates. Its non-GAAP profit of $2.85 per share was 1% above analysts’ consensus estimates.
Via StockStory · May 14, 2025
GSK acquires Boston Pharmaceuticals' efimosfermin for up to $2 billion, targeting liver diseases like MASH and ALD.
Via Benzinga · May 14, 2025
Q1 Earnings are much better than expected.
Via Talk Markets · May 14, 2025
Manufacturing company Illinois Tool Works (NYSE:ITW) met Wall Street’s revenue expectations in Q1 CY2025, but sales fell by 3.4% year on year to $3.84 billion. Its GAAP profit of $2.38 per share was 1% above analysts’ consensus estimates.
Via StockStory · May 14, 2025
The company’s revenue rose 17%, with subscription revenue improving 18% and operating margin expanding to 10%.
Via Stocktwits · May 14, 2025